Daniel Rea

Publications

  1. Published
  2. Published
  3. Published
  4. Published

    A phase I/II and pharmacokinetic study of irinotecan in combination with capecitabine as first line therapy for advanced colorectal cancer

    Daniel Rea, , , , , , , , , Neil Steven, , & , 25 May 2005, In: Annals of Oncology. 16, 7, p. 1123-1132 10 p.

    Research output: Contribution to journalArticle

  5. Published
  6. Published

    Acute non-myelosuppressive complications of systemic anticancer therapy

    Daniel Rea, 1 Aug 2008, In: Clinical Medicine. 8, 4, p. 439-442 4 p.

    Research output: Contribution to journalEditorial

  7. Published
  8. Published

    Addressing overtreatment of screen detected DCIS; the LORIS trial

    Toon Brookes, Tracy Roberts, Sarah Pirrie, Lucinda Billingham & 2 others, Sarah Bowden & Daniel Rea, Nov 2015, In: European Journal of Cancer. 51, 16, p. 2296-2303 8 p.

    Research output: Contribution to journalArticlepeer-review

  9. Published

    Adjuvant endocrine therapy for postmenopausal women with early stage breast cancer

    Daniel Rea, 1 Jan 2004, In: Therapy. 1, p. 1-14 14 p.

    Research output: Contribution to journalArticle

  10. Published
  11. Published

    Adjuvant tamoxifen: How long before we know how long?

    Daniel Rea, Christopher Poole & Richard Gray, 16 May 1998, In: BMJ. 316, 7143, 1 p.

    Research output: Contribution to journalArticlepeer-review

  12. Published

    Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial

    Daniel Rea, , , , , , , , , , , , , , & , 1 Jan 2011, In: Lancet. 377, 9762, p. 321-331 11 p.

    Research output: Contribution to journalArticle

  13. E-pub ahead of print

    Adjuvant tamoxifen and exemestane in postmenopausal early breast cancer: ten-year analysis of the randomised phase III TEAM trial

    Daniel Rea, , , , , & , 18 Jul 2017, (E-pub ahead of print) In: The Lancet Oncology.

    Research output: Contribution to journalArticlepeer-review

  14. Published
  15. Published

    Antibacterial prophylaxis after chemotherapy for solid tumours and lymphomas

    Neil Steven, Lucinda Billingham, , , , , Daniel Rea, , , & , 8 Sep 2005, In: New England Journal of Medicine. 353, 10, p. 988-998 11 p.

    Research output: Contribution to journalArticle

  16. Published

    Aromatase inhibitors versus tamoxifen in early breast cancer: Patient-level meta-analysis of the randomised trials

    Richard Gray & , 3 Oct 2015, In: The Lancet. 386, 10001, p. 1341-1352 12 p.

    Research output: Contribution to journalArticlepeer-review

  17. Published
  18. Published
  19. Published
  20. Published

    Breast screening saves lives: Now is the time to address overtreatment

    Daniel Rea & , 2014, In: Journal of Comparative Effectiveness Research. 3, 2, p. 111-113 3 p.

    Research output: Contribution to journalEditorialpeer-review

Previous 1 2 3 4 5 6 7 Next